Guidance

Meningococcal: the green book, chapter 22

Meningococcal immunisation information for public health professionals.

Documents

Meningococcal: the green book, chapter 22

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Update patch to chapter 22: 22 September 2015

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

Past chapter 22 update patches

Meningococcal disease occurs as a result of a systemic bacterial infection by Neisseria meningitidis. Meningococci are gram-negative diplococci, divided into antigenically distinct serogroups. They are classified according to characteristics of the polysaccharide capsule into capsular group, and of outer membrane proteins into type and subtype. Further characterisation, undertaken by sequencing several other regions of the chromosomal DNA, defines the sequence type (ST).